Daily metabolic patterns are regulated in a circadian manner often via the hypothalamic axis. Mukherji et al. now report a surprising role for commensal bacteria in the circadian regulation of glucocorticoid production by intestinal epithelial cells.
Glucocorticoid synthesis by intestinal epithelial cells (IECs) is a well-known example of a process regulated in a circadian manner, with its production being high during the active phase and decreased during the resting period (Asfeldt, 1971) . Previous research has mainly focused on the role of the hypothalamic-pituitary-adrenal (HPA) axis in controlling this daily pattern of production (Kino, 2012) . In this issue, Pierre Chambon and colleagues (Mukherji et al., 2013 ) take a decidedly different tack and ask whether the gut microbiota might play a role in this process. The microbiota encompass a diverse population of bacteria, archaea, and fungi populating many body sites of their multicellular hosts (Lozupone et al., 2012) . In mammals, their largest numbers are found in the gastrointestinal tract, with the highest concentrations present in the large intestine. These microbiota directly impact the metabolic status of their hosts (Tremaroli and Bä ckhed, 2012; Turnbaugh et al., 2006) . For instance, the composition of the gut microbial communities regulates the energy yield from food and modulates the levels of host-and dietderived products directly controlling metabolic pathways. Thus, not surprisingly, the microbiota are considered a key determinant of metabolic disease progression. However, the systemic impact of local (i.e., small and large intestine) pathways that are activated during symbiotic or abnormal host-microbiota interactions remains largely undetermined. Mukherji et al. unveil a surprising new link between the modulation of the circadian clock in IECs of the ileum by the microbiota and systemic metabolism.
Ileum IECs display a circadian temporal expression of clock genes, including RORa and RevErba, which in turn regulate numerous genes involved in IEC homeostatic functions. One of the most significant outcomes of IECs' circadian gene expression is their rhythmic production of corticosterone in an HPAaxis-independent manner. Strikingly, the authors find that depletion of the intestinal microbiota completely disrupts the circadian gene expression and the phasic production of corticosterone by the ileum, resulting in a sustained hypercorticosterolism with profound system consequences such as hyperglycemia, insulin resistance, and increased triglycerides and free fatty acids. These results not only provide an explanation for the increased triglycerides and hypoinsulinemia in germ-free mice, but also add another layer of complexity to the interactions between host metabolism and the intestinal microbiota. Indeed, it appears that their presence assists a regulatory network controlling the expression of Cyp11a1, an enzyme that catalyzes the first step in the conversion of cholesterol into steroid hormones. This rate-limiting step in corticosterone synthesis is regulated in the IECs through the clock gene E4BP4. The authors find that, in the presence of microbiota, this HPA-and ilealcontrolled glucocorticoid production is cophasic. In antibiotic-treated mice, this phasic production is, however, disrupted due to low E4BP4 expression and the resulting lack of Cyp11a1 repression.
But how does the intestinal microbiota regulate IEC circadian gene expression? A sequence of interdependent processes determines the answer to this question ( Figure 1 ). Among the hundreds of genes that are rhythmically regulated by RORa and RevErba are multiple innate immune receptors such as TLRs and NOD2. As a consequence, innate immune receptor signaling triggered by the constant exposure to the host microbiota also follows a rhythmic pattern. This rhythmic signaling through innate immune receptors, in turn, keeps the cogs of the IEC's clock synchronized by preventing the expression of the transcription factor PPARa and also establishes the downstream phasic production of corticosterone by the ileal IECs. Therefore, in the absence of cues from the microbiota, the main cogwheel of the IEC's clock is jammed by the constitutive expression of PPARa, leading to hypercorticosterolism.
Innate immune response pathways are evolutionarily conserved throughout species and are fundamental for survival, and nearly all organisms have developed mechanisms for anticipating environmental changes in order to coordinate physiological responses. Thus, it is not surprising that complex circadian regulation of innate immune receptors is starting to be elucidated from multiple angles. For instance, recent reports indicate that circadian clocks control the expression of the immune receptor TLR9 and that adaptive immune responses can be enhanced through immunization at times of increased TLR9 responsiveness (Silver et al., 2012) . Thus, the elucidation of an IEC circadian clock that regulates TLR expression and the finding that this clock is controlled by the presence of intestinal microorganisms represents another step forward in this exciting and emerging field. Moreover, it highlights the central 
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In the presence of microbiota (top), the RORa activator and the RevErba repressor have a phasic expression in ileal epithelial cells (IECs). In the active phase, the activity of RORa is dominant, which leads to the expression of innate immune receptors and the repressor protein E4BP4. In turn, E4BP4 represses the Cyp11a1 enzyme and therefore results in low corticosterone production. At the same time, the interaction between the intestinal microbiota and innate immune receptors prevents PPARa expression and therefore the expression of RevErba. In the resting phase, the activity of RevErba is dominant, which leads to the decreased level of the repressor protein E4BP4 and increased expression of Cyp11a1, resulting in high corticosterone synthesis. Without microbiota (bottom), the absence of microbiota-innate immune receptor interactions leads to a constant expression of PPARa and RevErba, which results in hypercosterolism with profound metabolic consequences.
role of microbiota-host interactions in hitherto seemingly unrelated physiological processes such as intestinal circadian clocks and systemic metabolism.
This study leaves us with several intriguing questions. First, which innate immune receptors are responsible for the regulation of the circadian clocks in IECs? Several TLRs and other receptors are expressed phasically, but deficiency in the major essential adaptor for most TLRs, MyD88, does not cause a similar phenotype. Some TLRs, such as TLR3 and TLR4, could still signal through the adaptor TRIF or alternative pathways that do not require MyD88, such as RIG-I-like receptors. A second question is whether different types of intestinal epithelial cells such as enterocytes, goblet cells, paneth cells, and stem cells differ in their regulation of the circadian clock. An intriguing possibility would be that one of these populations, for instance the paneth cells, could serve as pace makers, affecting other cellular subsets. Moreover, in light of the large body of recent work by groups including our own, which link specific members of the intestinal microbiota with metabolic disease (Henao-Mejia et al., 2012; Turnbaugh et al., 2006; Vijay-Kumar et al., 2010) , these findings raise the exciting question of whether specific members of the microbiota have exquisite abilities to influence the circadian rhythm and glucocorticoid synthesis. Finally, future research should decipher the particular importance of corticosterone production in the ileum and the relevance of the severe metabolic alterations associated with the disruption of this control mechanism for both local and systemic pathologies.
In this issue of Cell, Loffredo et al. demonstrate that exposing an old mouse to the circulatory system of a young mouse reverses age-related cardiac hypertrophy. The authors demonstrate that this effect can be recapitulated by treating old mice with growth and differentiation factor 11 (GDF11). These data suggest that GDF11 therapy may be a useful tool in combating age-related cardiac hypertrophy.
Within the context of an increasingly aged population, the healthcare costs associated with aging-related heart failure represent a significant healthcare burden. Diastolic heart failure, characterized by impaired cardiac filling during relaxation, in particular, is a condition lacking specific and effective therapies (Hunt et al., 2009; Kitzman and Daniel, 2007) . Though perhaps controversial, there appears to be an association between an age-related increase in cardiac mass (i.e., cardiac hypertrophy) and the development of diastolic dysfunction (Dai and Rabinovitch, 2009; Lakatta and Levy, 2003) . Agerelated cardiac hypertrophy has been described in humans and animal models, but the physiological, hormonal, cellular, and molecular causes remain poorly understood. Here, Loffredo et al. demonstrate that exposing an old mouse to the circulation of a young mouse using a powerful technique called parabiosis can reverse many of the biological consequences of age-related cardiac hypertrophy (Loffredo et al., 2013) . The authors go on to establish that this effect appears to be at least partially modulated by a circulating protein called growth and differentiation factor 11 (GDF11).
The traditional technique of parabiosis involves joining the vasculature of two animals such that the two animals
